Techsonian (press release) The company's lead product candidate is vosaroxin, an anti-cancer quinolone derivative for the treatment of acute myeloid leukemia or AML. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)declined -2.87% and closed at $1.69 in the last trading session with ... and more »
Street Newswire (registration) Redhill Biopharma Ltd – ADR (NASDAQ:RDHL) jumped briefly this morning before dipping into the red recently in the U.S. pre-market session on Monday after the U.S. FDA granted a Qualified Infectious Disease Product (QIDP) fast-track designation to its ... and more »
Nasdaq QINPREZO™ (vosaroxin) is an anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer. Preclinical data demonstrate that QINPREZO both intercalates DNA and inhibits topoisomerase II, ... and more »
AAP News (subscription) Of concern, however, was that 68% of the isolates were resistant to nalidixic acid (a quinolone antibiotic), which is used in the laboratory to test for resistance. The concern is based on that fact that quinolones are one of the antibiotics commonly ... and more »
Medscape Available anti-malarial tools have over the ten-year period prior to 2012 dramatically reduced the number of fatalities due to malaria from one million to less than six-hundred and thirty thousand. Although fewer people now die from malaria, emerging ...
